BlackRock Investment Management’s Immune Design Corp. IMDZ Stock Holding History

BlackRock Investment Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$304K	Buy	55,251 +2,090	+4%	+$14.8K	﹤0.01%	3163
2016 Q3	$403K	Buy	53,161 +11,285	+27%	+$82.5K	﹤0.01%	3115
2016 Q2	$342K	Buy	41,876 +2,365	+6%	+$29.5K	﹤0.01%	3199
2016 Q1	$514K	Buy	39,511 +654	+2%	+$7.55K	﹤0.01%	2895
2015 Q4	$780K	Buy	38,857 +69	+0.2%	+$1.19K	﹤0.01%	2763
2015 Q3	$473K	Sell	38,788 -7,113	-15%	-$133K	﹤0.01%	3048
2015 Q2	$948K	Buy	45,901 +27,862	+154%	+$658K	﹤0.01%	2807
2015 Q1	$381K	Buy	18,039 +460	+3%	+$12K	﹤0.01%	3062
2014 Q4	$541K	Buy	17,579 +3,374	+24%	+$93.8K	﹤0.01%	2961
2014 Q3	$251K	Buy	+14,205	New	+$180K	﹤0.01%	3212

Other funds holding IMDZ

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Investment Management's IMDZ Position: Q4 2016 in Review

BlackRock Investment Management increased its Immune Design Corp. (IMDZ) stake by 3.9% in Q4 2016, buying an estimated $14.8K and bringing the position to 55,251 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

BlackRock Investment Management first reported a position in IMDZ in Q3 2014 and has held it in 10 quarters since. The position peaked at $948K in Q2 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

BlackRock Investment Management held 55,251 shares of Immune Design Corp. worth $304K as of Q4 2016.
BlackRock Investment Management bought 2,090 Immune Design Corp. shares in Q4 2016, an estimated $14.8K.
Immune Design Corp. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3163 holding.
BlackRock Investment Management first reported a position in Immune Design Corp. in Q3 2014 and has held it in 10 quarters since.
BlackRock Investment Management's Immune Design Corp. position peaked at $948K in Q2 2015.
65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.